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Objective. To compare the infectious complication rates from cesarean delivery of human immunodeﬁciency virus (HIV)-
infected women and HIV-negative women. Materials and Methods. A retrospective analysis was performed on data derived from
HIV-infected women and HIV-negative women, who underwent cesarean delivery at two teaching hospitals. Main outcome
measures were infectious postoperative morbidity. Descriptive, comparison analysis, and multiple logistic regression analysis were
performed. Results. One hundred and nineteen HIV-infected women and 264 HIV-negative women delivered by cesarean section
and were compared. The HIV-negative women were more likely than the HIV-infected women to deliver by emergent cesarean
section (78.0% versus 51.3%, resp., P<. 05), to labor prior to delivery (69.4% versus 48.3%, resp., P<. 01), and to have ruptured
membranes prior to delivery (63.5% versus 34.8%, resp., P<. 05). In bivariate analysis, HIV-infected and HIV-negative women
had similar rates of post-operative infectious complications (16.8% versus 19.7%, resp., P>. 05). In a multivariate stepwise
logistic analysis, emergent cesarean delivery and chorioamnionitis but not HIV infection were associated with increased rate of
post-operative endometritis (odds ratio (OR) 4.10, 95% conﬁdence interval (95% CI) 1.41–11.91, P<. 01, and OR 3.02, 95% CI
1.13–8.03, P<. 05, resp.). Conclusion. In our facilities, emergent cesarean delivery and chorioamnionitis but not HIV infection
were identiﬁed as risk factors for post-operative endometritis.
Copyright © 2009 Helen Cavasin et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Theoriginallandmarkstudy,PACTG076reportedadecrease
in the vertical transmission of human immunodeﬁciency
virus (HIV) infection from mother to child from 25% to
8% with the use of zidovudine in the antenatal, intrapartum,
and neonatal periods [1]. More recently, cesarean section
has been recommended in women with viral load above
1000copies/mL to further prevent vertical transmission of
HIV [2]. While there are many studies supporting the bene-
ﬁtsofthecombinationofcesareandeliveryandantiretroviral
medications in preventing vertical transmission of HIV dis-
ease from mother to child [3–8], there are also reports on the
morbiditiesthatHIV-infectedwomenincurredfromsurgical
procedures [9–11]. Previous reports on the morbidities of
cesarean deliveries implied that even healthy, nonimmun-
odeﬁcient women could sustain signiﬁcant complications
[12, 13]. Thus, it would appear that HIV-infected women
may have even more post-operative complications, especially
the infectious morbidities, due to their immunodeﬁcient
status when they underwent cesarean delivery in an attempt
to decrease vertical transmission of the HIV disease.
Current available data reported conﬂicting results with
regardtothepost-operativemorbiditiesexperiencedbyHIV-
infected women [4, 9–11, 14, 15], therefore, we undertook
this study to further examine and compare the infectious
complication rate from cesarean delivery of HIV-infected
women with those of HIV negative women.
2.MaterialsandMethods
A retrospective analysis was performed on data obtained
from women who presented at two teaching medical institu-
tions, the Medical Center of Louisiana at New Orleans - Uni-
versity Campus and Tulane Health Sciences Center, and who2 Infectious Diseases in Obstetrics and Gynecology
subsequently underwent a cesarean section. This study was
approved by the Institutional Review Board. Identiﬁcation of
the study patients (HIV-infected women) was obtained by
reviewing the labor and delivery log. Their available medical
records were reviewed for data abstraction. Control subjects
were HIV-seronegative women who delivered by cesarean
section during the same time period and whose medical
records were available for review.
Medical records were reviewed and data was collected
on maternal demographics, number of previous cesarean
deliveries, estimated gestational age at time of delivery,
classiﬁcation of cesarean delivery as elective or emergent,
pre-operative hematocrit values on the day of delivery,
membrane status, application of internal monitoring device,
type of anesthesia, skin incision, uterine incision, operative
time, estimated blood loss, post-operative morbidities, HIV
status, CD4 lymphocyte count, and viral load.
For this study, elective cesarean delivery was deﬁned
as a planned operation without signs of labor prior to
surgery. Emergent cesarean delivery was deﬁned as surgery
performed after the presence of regular uterine contractions
with or without rupture of membranes and for maternal
and/or fetal indications, such as nonreassuring fetal heart
rate status, arrest disorders, and third trimester bleeding.
Post-operative infectious morbidities that were evaluated
in this study included endometritis (deﬁned as temperature
elevation above 38
◦C with uterine tenderness and requiring
antibiotics treatment in the absence of other etiology for
the fever), urinary tract infection, septic pelvic throm-
bophlebitis, pneumonia, and superﬁcial or deep wound
breakdown at the time of discharge from the hospital.
At the above teaching institutions, the management of
the patients was conducted by resident physicians under the
supervision of Maternal-Fetal Medicine specialist or general
obstetricianwithconsultationfromMaternal-FetalMedicine
specialist as indicated. The management of patients was
within the standard of current obstetric care. All patients
received prophylactic pre-operative antibiotics.
Data was analyzed using SPSS-11 Software (SPSS Inc.,
Chicago, Ill.). Chi-square analysis with Fischer exact when
necessary, Student’s t-test, and multiple logistic regression
analysis were performed when appropriate. Statistical signif-
icance was assumed at P<. 05.
3. Results
Over the study period, from July 1998 to December 2004,
119 HIV infected women delivered by cesarean section at
the above two teaching institutions. Data was collected
on 264 HIV-negative women who delivered by cesarean
section during this time and served as the controls. Maternal
characteristics of the two groups are presented in Table 1.
Overall, the majority of the patients were African American
(92.1% of HIV-infected group and 84.3% of HIV-negative
group, P<. 05). Both groups demonstrated a high body
mass index (32.7 ± 7.8kg/m 2 in HIV-infected group versus
33.6 ± 8.2k g / m 2 in HIV-negative group, P>. 05). The CD4
lymphocyte count and viral load near time of delivery of
the HIV-infected group were evaluated; 78.8% of the HIV-
infected women had a CD4 lymphocyte count of ≥200 and
19.2% had undetectable viral load (Table 1).
Obstetrical characteristics of the two groups are com-
pared in Table 2. There was no signiﬁcant diﬀerence between
theHIV-infectedgroupandtheHIV-negativegroupinterms
of gravidity, parity, number of previous cesarean sections,
estimated gestational age at time of delivery, and rate of
chorioamnionitis. HIV-infected women were signiﬁcantly
more likely to have a lower preoperative hematocrit than
the HIV-negative women (31.9 ± 3.8% versus 33.6 ± 3.8%,
resp., P<. 01). HIV-negative women were signiﬁcantly
morelikelythanHIV-infectedpatientstodeliverbyemergent
cesarean section (78.0% versus 51.3%, resp., P<. 01), to
labor prior to delivery (69.4% versus 48.3%, resp., P<. 01),
to have ruptured membranes prior to delivery (63.5% versus
34.8%, resp., P<. 01), and to have application of internal
monitoring devices during labor (31.5% versus 6.0%, resp.,
P<. 01).
The surgical characteristics of cesarean delivery in both
HIV-infected and HIV-negative women are presented in
Table 3. Pfannenstiel skin incision were more often per-
formed in HIV-infected women than their controls (94.5%
versus 82.7%, resp., P<. 01). There was no statisti-
cal diﬀerence in the other characteristics reviewed which
included the type of anesthesia, the type of uterine incision,
the estimated blood loss during surgery, or the operative
time. Postoperative infectious morbidities are presented in
Table 4. There was no signiﬁcant diﬀerence in the infectious
morbidities between the HIV infected women and the
control group. The most common infectious morbidity after
cesarean delivery for our study population is postpartum
endometritis.
Furthermore, there was no statistical signiﬁcant dif-
ference between the mean ± SD CD4 lymphocyte count
between the HIV-infected women with infectious morbidity
and those without infectious morbidity (413.2 ± 257.9
cells/mm3 and 465.4 ± 283.7cells/mm3,r e s p . ,P>. 05), and
between the mean ± SD viral load of those with infectious
morbidity and those without infectious morbidity (26,967.1
± 79,491.6 copies/ml and 43,7242.9 ± 123,389.8 copies/mL,
resp., P>. 05).
Postoperative infectious morbidity in both groups was
analyzed according to whether the cesarean section was
an elective or emergent delivery. Both groups of women
were statistically more likely to experience postpartum
endometritis when being delivered by emergent cesarean
sectionthanbyelectivecesareansection,(21.3%versus3.4%,
resp., P<. 05 in HIV-infected women and 14.6% versus
3.5%, resp., P<. 05 in HIV-negative women).
Postpartum endometritis composed the majority of
the post-operative infectious morbidity, and HIV-negative
women in our study had signiﬁcantly more obstetrics risk
factors for postpartum endometritis than the HIV-infected
women. Those risk factors were: delivery by emergent
cesarean section, rupture of membranes and labor prior
to delivery, and insertion of internal monitoring. Because
of that, we further performed logistic regression analysis,
controlling for these risk factors to determine whether HIVInfectious Diseases in Obstetrics and Gynecology 3
Table 1: Maternal characteristics.
HIV-infected HIV-negative P-value
Age (years) 24.6 ± 5.1 25.7 ±6.7N S
Race
African American 105 (92.1%) 210 (84.3%) <.05
Others
∗ 9 (7.9%) 39 (15.7%) <.05
Maternal weight (kg) 88.9 ±23.18 9 .8 ±23.2N S
Maternal height (m) 1.6 ± .07 1.6 ± .07 NS
BMI (kg/m2)3 2 .7 ±7.83 3 .6 ±8.2N S
Mean CD Count (n = 80) 455.0 ±277.9 —
Women with CD4 count ≥200 cells/mm3 63 (78.8%)
Mean viral load (copies/ml) (n = 73) 40,295.8 ± 115,448.8 —
Women with undetectable viral load (<400 copies/ml) 14 (19.2%)
Data presented as number and percent or mean ± standard deviation.
NS = Not signiﬁcant.
∗Others include: Caucasian, Hispanic, and Asian.
Table 2: Obstetrical characteristics.
HIV-infected HIV-negative P-value
Gravidity 2.9 ±2.02 .8 ± 1.9N S
Parity 1.6 ±1.81 .4 ± 1.6N S
No. of previous c/s
0 64 (58.7%) 146 (56.2%) NS
1 28 (25.7%) 61 (23.5%) NS
2 12 (11.0%) 34 (13.1%) NS
3 3 (2.8%) 13 (5.0%) NS
4 1 (.9%) 6 (2.3%) NS
5 1 (.9%) 0 NS
EGA at delivery (weeks) 37.4 ±3.13 7 .7 ±3.4N S
Preoperative Hematocrit (%) 31.9 ±3.83 3 .6 ±3.8 <.01
Emergent cesarean delivery 61 (51.3%) 206 (78.0%) <.01
Labor prior to delivery 56 (48.3%) 179 (69.4%) <.01
Rupture of membranes prior to delivery 40 (34.8%) 165 (63.5%) <.01
Use of internal monitor 7 (6.0%) 82 (31.5%) <.01
Chorioamnionitis 5 (4.3%) 18 (6.8%) NS
Data presented as mean ± standard deviation or number and percent.
NS = Not signiﬁcant.
Table 3: Description of surgical procedures.
HIV-infected HIV-negative P-value
Anesthesia
General 10 (8.6%) 30 (11.6%) NS
Regional 106 (91.4%) 229 (88.4%) NS
Skin Incision
Pfannenstiel 104 (94.5%) 215 (82.7%) <.01
Midline 6 (5.5%) 45 (17.3%) <.01
Uterine Incision
Low transverse 110 (95.7%) 248 (94.7%) NS
Classical/low transverse 5 (4.3%) 14 (5.3%) NS
with vertical extension
Estimated blood loss (cc) 857.4 ±311.2 880.0 ±364.5N S
Operative time (min) 69.5 ±34.97 4 .9 ±33.0N S
Data presented as mean ± standard deviation or number and percent.
NS = Not signiﬁcant.4 Infectious Diseases in Obstetrics and Gynecology
Table 4: Postoperative infectious complications among HIV-
infected women and HIV-negative women.
HIV-infected HIV-
negative
P-
value
Infectious complications 20 (16.8%) 52 (19.7%) NS
Endometritis 15 (12.6%) 32 (12.1%) NS
Urinary tract infection 2 (1.7%) 15 (5.7%) NS
Superﬁcial wound breakdown 1 (0.8%) 5 (1.9%) NS
Deep wound breakdown 1 (0.8%) 3 (1.1%) NS
SPT
∗ 0 5 (1.9%) NS
Pneumonia 2 (1.7%) 3 (1.1%) NS
Data presented as number and percent.
∗SPT = Septic pelvic thrombophlebitis.
NS = Not signiﬁcant.
infection play a signiﬁcant role in postpartum endometritis.
To identify risk factors inﬂuencing the risk of postpartum
endometritis, we constructed a stepwise proportional odds
model. HIV infectious status, emergent cesarean deliv-
ery, ruptured membranes prior to delivery, application of
internal monitoring devices during labor, chorioamnionitis,
and preoperative hematocrit were included in the model-
building. HIV infectious status, rupture of membranes prior
to cesarean delivery, application of internal monitoring
devices during labor, and preoperative hematocrit were not
found to be signiﬁcant predictors of endometritis (P>. 05).
However, the odds of having endometritis were almost 4
times higher in emergent cesarean delivery (odds ratio (OR)
4.1, 95% Conﬁdence interval (CI) 1.41–1.91, P = .009)
and 3 times higher in those with chorioamnionitis during
labor (OR 3.02, 95% CI 1.13–8.03, P = .027). It should
be noted that because colinearity was present between labor
prior to delivery by emergent cesarean section and emergent
cesarean delivery, we only included emergent cesarean
deliveryinthemultivariatestepwiselogisticregressionmodel
(Table 5).
4. Discussion
According to our study, there was not a signiﬁcant diﬀer-
ence in infectious postoperative morbidity in HIV infected
women who delivered by cesarean section when com-
pared to their cohorts of HIV-negative women. However,
logistic regression analysis highlighted the increased risk
of postpartum endometritis in women who delivered by
emergent cesarean section and who had chorioamnioni-
tis during labor, controlling for covariates including HIV
infectious status. The HIV infected women in this study
were signiﬁcantly less likely than the control subjects to
deliver by emergent cesarean delivery (51.3% versus 78.0%,
resp., P<. 01) and should, therefore, have had a lower
rate of postpartum endometritis. Since we observed sim-
ilar rates of postpartum endometritis in the two groups,
despite the fact that HIV-infected women had less risk
factors for postpartum endometritis, we can speculate
that HIV infection may be a risk factor for postpartum
endometritis after cesarean section. However, because of
the small sample size, we do not ﬁnd statistical evidence
that HIV infection resulted in higher infectious morbidity
after cesarean delivery as reported in some previous studies
[8–11, 16–21]. A possible explanation for our result is
that we reported on a population of HIV-infected women
who were reasonably immunocompetent. The mean ±
SD CD4 lymphocyte count of our study population was
455.0 ± 277.9 and 78.8% had a CD4 lymphocyte count
of at least 200 or greater. Most studies reported the
increased risk of postoperative infectious morbidities to be
associated with the severe degree of immune suppression
[9, 17].
Stratiﬁed analysis by whether cesarean delivery was
emergent or elective in HIV infected women demonstrated
that emergent cesarean delivery increased postoperative
endometritis over elective cesarean delivery. This is consis-
tent with previous studies which have also demonstrated
the highest risk of postoperative morbidity occurring in
HIV-infected women who deliver by emergent cesarean
section [11, 20, 21] .T h e r e f o r ea sa nH I V - i n f e c t e dw o m a n
considers elective cesarean delivery or attempt at vaginal
delivery, our counseling should include the increased risk of
developing postoperative endometritis should her attempt at
vaginal delivery fail and emergent cesarean delivery become
necessary. We agreed with Marcollet’s recommendation
that women with a low probability of having a successful
vaginal delivery should consider scheduled cesarean delivery
[14]. Current ACOG guidelines on recommending elective
cesarean delivery for HIV infected women to reduce vertical
transmission emphasize the importance of performing the
surgery prior to the onset of labor or rupture of membranes
[2]. Cesarean delivery performed after the onset of labor
or rupture of membranes (i.e., Emergent cesarean delivery)
is of unclear beneﬁt with regard to decreasing the vertical
transmission risk [2]. Thus, it is important to adhere to
the ACOG recommendation on elective cesarean delivery
for HIV-infected women as a mean to further reduce
vertical transmission rate, as the beneﬁts of cesarean delivery
performed after labor or rupture of membranes is unknown
and based on current study and other reports [11, 14,
20, 21], maternal infectious morbidity is greater at times
of emergent cesarean delivery when compared to elective
cesarean delivery.
Limitations of this study include the small number of
study patients with severe HIV disease status as determined
by CD4 lymphocyte counts and viral load quantiﬁca-
tions. Thus, we were not able to demonstrate the associa-
tion between post-operative morbidity among HIV-infected
women and the severity of their diseases. Larger study
populations are necessary to truly examine the impact of
disease status on postoperative morbidity in HIV-infected
patients. We also did not evaluate the use of antiretroviral
medications and are unable to comment on any possible
eﬀects that these medications may have had on postoperative
morbidity.Thisstudywasalsolimitedduetoitsretrospective
approach to data collection. A large prospective study will
better evaluate the post-operative morbidities of cesarean
delivery in HIV-infected women.Infectious Diseases in Obstetrics and Gynecology 5
Table 5: Risk factors variables inﬂuencing postpartum endometritis in a stepwise odds model.
∗
Riskfactors
† Estimate Odds of postpartum endometritis P value
β SE
‡ OR
‡ 95%CI
‡
Intercept −4.62 1.04 —— <.0001
Emergent cesarean delivery 1.41 0.54 4.10 1.41–11.91 .009
Chorioamnionitis 1.10 0.50 3.02 1.13–8.03 .027
∗Model-building for emergent cesarean delivery: β0 + β1 HIV status + β2 experienced rupture of membranes prior to cesarean delivery + β3 placement of
internal monitoring devices during labor + β4 Chorioamnionitis + β5 hematocrit + β6 indication of cesarean delivery.
†Reference group: elective cesarean delivery, absence of chorioamnionitis.
‡SE, Standard error; OR, odds ratio; CI, conﬁdence interval.
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